Analysis of volatile organic compounds in exhaled breath after radiotherapy.
- Author:
Dianlong GE
1
;
Xue ZOU
2
;
Yajing CHU
1
;
Jijuan ZHOU
1
;
Wei XU
1
;
Yue LIU
1
;
Qiangling ZHANG
1
;
Yan LU
1
;
Lei XIA
1
;
Aiyue LI
1
;
Chaoqun HUANG
1
;
Pei WANG
3
;
Chengyin SHEN
1
;
Yannan CHU
1
Author Information
- Publication Type:Journal Article
- MeSH: Breath Tests/methods*; Exhalation; Humans; Quality of Life; Respiratory System/chemistry*; Volatile Organic Compounds/analysis*
- From: Journal of Zhejiang University. Science. B 2022;23(2):153-157
- CountryChina
- Language:English
- Abstract: Radiotherapy uses high-energy X-rays or other particles to destroy cancer cells and medical practitioners have used this approach extensively for cancer treatment (Hachadorian et al., 2020). However, it is accompanied by risks because it seriously harms normal cells while killing cancer cells. The side effects can lower cancer patients' quality of life and are very unpredictable due to individual differences (Bentzen, 2006). Therefore, it is essential to assess a patient's body damage after radiotherapy to formulate an individualized recovery treatment plan. Exhaled volatile organic compounds (VOCs) can be changed by radiotherapy and thus used for medical diagnosis (Vaks et al., 2012). During treatment, high-energy X-rays can induce apoptosis; meanwhile, cell membranes are damaged due to lipid peroxidation, converting unsaturated fatty acids into volatile metabolites (Losada-Barreiro and Bravo-Díaz, 2017). At the same time, radiotherapy oxidizes water, resulting in reactive oxygen species (ROS) that can increase the epithelial permeability of pulmonary alveoli, enabling the respiratory system to exhale volatile metabolites (Davidovich et al., 2013; Popa et al., 2020). These exhaled VOCs can be used to monitor body damage caused by radiotherapy.
